Your Trusted Source for Biopharma News

Editorial

View All
Your Trusted Source for Biopharma News
Editorial Biopharma's 2026 Playbook: AI, M&A, and the Race for Pipeline Security

The partnership between Eli Lilly and NVIDIA to build a supercomputer capable of running trillions of molecular simulations is a signal that biopharma’s approach to drug discovery is changing at a s…

MindWalk and Teva Team Up to Advance AI Antibody Discovery
EditorialMindWalk and Teva Team Up to Advance AI Antibody Discovery

Over the past few years, applying AI to drug discovery has become a crowded, well-funded field. In

Regenerative Medicine and Rare Disease Therapy Innovations
EditorialRegenerative Medicine and Rare Disease Therapy Innovations

The move from research-level discovery to established clinical use is a critical juncture that

Seven Biopharma Trends to Watch in 2026
EditorialSeven Biopharma Trends to Watch in 2026

The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at

From Breakthroughs to Scale: Biopharma Platforms Shaping 2026
EditorialFrom Breakthroughs to Scale: Biopharma Platforms Shaping 2026

In 2026, boards and customers are asking a direct question: can promising science be turned into

View All

Research & Development

View All
View All

Tech & Innovation

View All
View All
Patients Are Not Fully Sold on AI in Health Care
Tech & Innovation Patients Are Not Fully Sold on AI in Health Care

Americans will accept artificial intelligence for some routine work in medicine, a new Pew Research Center survey found. But Americans get less comfortable when AI handles medical decisions without a person checking the work, and that leaves hospitals and health tech companies with two things to

How AI and Nanotechnology Are Transforming Brain Cancer Treatment
Tech & InnovationHow AI and Nanotechnology Are Transforming Brain Cancer Treatment

The brain tumor microenvironment is notoriously immunologically cold, utilizing inhibitory

Boltz Raises $110 Million to Scale Molecular Intelligence
Tech & InnovationBoltz Raises $110 Million to Scale Molecular Intelligence

The emergence of "agentic" scientific exploration allows AI agents to autonomously set up

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later